{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T12:35:17Z","timestamp":1792931717799,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273130"],"award-info":[{"award-number":["82273130"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.redox.2026.104415","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:18:30Z","timestamp":1790320710000},"page":"104415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The ribonuclease ZC3H12A stabilizes BRCA1 mRNA in DNA damage response"],"prefix":"10.1016","volume":"97","author":[{"given":"Mingjun","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabao","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhendong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyue","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8360-1543","authenticated-orcid":false,"given":"Teng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.redox.2026.104415_bib1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nrg3345","article-title":"Chromatin and the genome integrity network","volume":"14","author":"Papamichos-Chronakis","year":"2013","journal-title":"Nat. Rev. Genet."},{"issue":"3","key":"10.1016\/j.redox.2026.104415_bib2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.pharmthera.2012.10.009","article-title":"Targeting DNA repair mechanisms in cancer","volume":"137","author":"Furgason","year":"2013","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.redox.2026.104415_bib3","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.tcb.2015.07.009","article-title":"Repair pathway choices and consequences at the double-strand break","volume":"26","author":"Ceccaldi","year":"2016","journal-title":"Trends Cell Biol."},{"issue":"1","key":"10.1016\/j.redox.2026.104415_bib4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0959-8049(92)90432-2","article-title":"DNA damage by drugs and radiation: what is important and how is it measured?","volume":"28","author":"Whitaker","year":"1992","journal-title":"Eur. J. Cancer"},{"issue":"8","key":"10.1016\/j.redox.2026.104415_bib5","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41580-025-00841-4","article-title":"Mechanisms and regulation of DNA end resection in the maintenance of genome stability","volume":"26","author":"Ceccaldi","year":"2025","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"33","key":"10.1016\/j.redox.2026.104415_bib6","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1038\/onc.2012.556","article-title":"Various modes of cell death induced by DNA damage","volume":"32","author":"Surova","year":"2013","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.redox.2026.104415_bib7","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41392-021-00648-7","article-title":"DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"3","key":"10.1016\/j.redox.2026.104415_bib8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nrc3891","article-title":"Therapeutic opportunities within the DNA damage response","volume":"15","author":"Pearl","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.redox.2026.104415_bib9","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41568-021-00386-6","article-title":"Targeting the DNA damage response in immuno-oncology: developments and opportunities","volume":"21","author":"Chabanon","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"21","key":"10.1016\/j.redox.2026.104415_bib10","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1158\/0008-5472.CAN-20-1830","article-title":"BRCA1 mutations in cancer: coordinating deficiencies in homologous recombination with tumorigenesis","volume":"80","author":"Krais","year":"2020","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.redox.2026.104415_bib11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.tcb.2025.05.002","article-title":"New twist on BRCA1-mediated DNA recombination repair and tumor suppression","volume":"36","author":"Zong","year":"2026","journal-title":"Trends Cell Biol."},{"issue":"10","key":"10.1016\/j.redox.2026.104415_bib12","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.tibs.2012.06.007","article-title":"Links between genome integrity and BRCA1 tumor suppression","volume":"37","author":"Li","year":"2012","journal-title":"Trends Biochem. Sci."},{"issue":"7676","key":"10.1016\/j.redox.2026.104415_bib13","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nature24060","article-title":"BRCA1-BARD1 promotes RAD51-mediated homologous DNA pairing","volume":"550","author":"Zhao","year":"2017","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.redox.2026.104415_bib14","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s41580-020-0218-z","article-title":"The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication","volume":"21","author":"Tarsounas","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7766","key":"10.1016\/j.redox.2026.104415_bib15","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41586-019-1363-4","article-title":"Isomerization of BRCA1-BARD1 promotes replication fork protection","volume":"571","author":"Daza-Martin","year":"2019","journal-title":"Nature"},{"issue":"8033","key":"10.1016\/j.redox.2026.104415_bib16","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41586-024-07910-2","article-title":"Promotion of DNA end resection by BRCA1-BARD1 in homologous recombination","volume":"634","author":"Salunkhe","year":"2024","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.redox.2026.104415_bib17","doi-asserted-by":"crossref","first-page":"11080","DOI":"10.1093\/nar\/gkad793","article-title":"BRCA1-BARD1 combines multiple chromatin recognition modules to bridge nascent nucleosomes","volume":"51","author":"Burdett","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"20","key":"10.1016\/j.redox.2026.104415_bib18","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1016\/j.molcel.2023.09.015","article-title":"Crucial roles of the BRCA1-BARD1 E3 ubiquitin ligase activity in homology-directed DNA repair","volume":"83","author":"Wang","year":"2023","journal-title":"Mol. Cell"},{"issue":"22","key":"10.1016\/j.redox.2026.104415_bib19","doi-asserted-by":"crossref","first-page":"9469","DOI":"10.1158\/0008-5472.CAN-08-1159","article-title":"Posttranscriptional regulation of the breast cancer susceptibility gene BRCA1 by the RNA binding protein HuR","volume":"68","author":"Saunus","year":"2008","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.redox.2026.104415_bib20","article-title":"Widespread BRCA1\/2-independent homologous recombination defects are caused by alterations in RNA-binding proteins","volume":"4","author":"McGrail","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"3","key":"10.1016\/j.redox.2026.104415_bib21","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1158\/1078-0432.CCR-13-0225","article-title":"Molecular pathways: how can BRCA-mutated tumors become resistant to PARP inhibitors?","volume":"20","author":"Bouwman","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"13","key":"10.1016\/j.redox.2026.104415_bib22","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1158\/1078-0432.CCR-18-0968","article-title":"PARP inhibitors: extending benefit beyond BRCA-Mutant cancers","volume":"25","author":"Pili\u00e9","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.redox.2026.104415_bib23","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s13238-012-2075-9","article-title":"MCP-1-induced protein-1, an immune regulator","volume":"3","author":"Xu","year":"2012","journal-title":"Protein Cell"},{"issue":"5","key":"10.1016\/j.redox.2026.104415_bib24","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/cmi.2016.70","article-title":"Regnase-1, a rapid response ribonuclease regulating inflammation and stress responses","volume":"14","author":"Mao","year":"2017","journal-title":"Cell. Mol. Immunol."},{"issue":"7242","key":"10.1016\/j.redox.2026.104415_bib25","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/nature07924","article-title":"Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay","volume":"458","author":"Matsushita","year":"2009","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.redox.2026.104415_bib26","doi-asserted-by":"crossref","first-page":"6957","DOI":"10.1093\/nar\/gks359","article-title":"Structural study of MCPIP1 N-terminal conserved domain reveals a PIN-like RNase","volume":"40","author":"Xu","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"10.1016\/j.redox.2026.104415_bib27","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/ni.2137","article-title":"The I\u03baB kinase complex regulates the stability of cytokine-encoding mRNA induced by TLR-IL-1R by controlling degradation of regnase-1","volume":"12","author":"Iwasaki","year":"2011","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.redox.2026.104415_bib28","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/s13046-019-1430-6","article-title":"Activity of MCPIP1 RNase in tumor associated processes","volume":"38","author":"Miekus","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.redox.2026.104415_bib29","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s13238-020-00739-1","article-title":"How are MCPIP1 and cytokines mutually regulated in cancer-related immunity?","volume":"11","author":"Xu","year":"2020","journal-title":"Protein Cell"},{"issue":"7787","key":"10.1016\/j.redox.2026.104415_bib30","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41586-019-1821-z","article-title":"Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy","volume":"576","author":"Wei","year":"2019","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.redox.2026.104415_bib31","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1084\/jem.20181078","article-title":"Phosphorylation-dependent Regnase-1 release from endoplasmic reticulum is critical in IL-17 response","volume":"216","author":"Tanaka","year":"2019","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.redox.2026.104415_bib32","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1093\/nar\/gkab316","article-title":"PIN and CCCH Zn-finger domains coordinate RNA targeting in ZC3H12 family endoribonucleases","volume":"49","author":"Garg","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.redox.2026.104415_bib33","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/978-1-61779-998-3_27","article-title":"I-SceI-based assays to examine distinct repair outcomes of mammalian chromosomal double strand breaks","volume":"920","author":"Gunn","year":"2012","journal-title":"Methods Mol. Biol."},{"issue":"5","key":"10.1016\/j.redox.2026.104415_bib34","first-page":"173","article-title":"Cisplatin: synthesis, antitumour activity and mechanism of action","volume":"7","author":"Reedijk","year":"1985","journal-title":"Pharm. World Sci."},{"issue":"10","key":"10.1016\/j.redox.2026.104415_bib35","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrc1977","article-title":"Topoisomerase I inhibitors: camptothecins and beyond","volume":"6","author":"Pommier","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"17","key":"10.1016\/j.redox.2026.104415_bib36","first-page":"3976","article-title":"Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis","volume":"53","author":"Kaufmann","year":"1993","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.redox.2026.104415_bib37","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0092-8674(00)80430-4","article-title":"Caspases: intracellular signaling by proteolysis","volume":"91","author":"Salvesen","year":"1997","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.redox.2026.104415_bib38","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.molcel.2022.02.021","article-title":"The expanding universe of PARP1-mediated molecular and therapeutic mechanisms","volume":"82","author":"Huang","year":"2022","journal-title":"Mol. Cell"},{"issue":"22","key":"10.1016\/j.redox.2026.104415_bib39","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1200\/JCO.2008.16.0812","article-title":"A synthetic lethal therapeutic approach: poly(adp) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair","volume":"26","author":"Ashworth","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"17","key":"10.1016\/j.redox.2026.104415_bib40","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1038\/s41388-021-01744-2","article-title":"Exploiting synthetic lethality to target BRCA1\/2-deficient tumors: where we stand","volume":"40","author":"Patel","year":"2021","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.redox.2026.104415_bib41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.tcb.2021.07.005","article-title":"DNA replication: the recombination connection","volume":"32","author":"Epum","year":"2022","journal-title":"Trends Cell Biol."},{"issue":"7","key":"10.1016\/j.redox.2026.104415_bib42","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1101\/gr.258848.119","article-title":"Binding specificities of human RNA-binding proteins toward structured and linear RNA sequences","volume":"30","author":"Jolma","year":"2020","journal-title":"Genome Res."},{"issue":"5376","key":"10.1016\/j.redox.2026.104415_bib43","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/240100a0","article-title":"Stability of HeLa cell mRNA in actinomycin","volume":"240","author":"Singer","year":"1972","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.redox.2026.104415_bib44","article-title":"Beyond repair: expanding roles of BRCA1 in RNA processing and cancer","volume":"1880","author":"Poorbagher","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"issue":"18","key":"10.1016\/j.redox.2026.104415_bib45","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1158\/0008-5472.CAN-22-1535","article-title":"BRCA1-Dependent and independent recruitment of PALB2-BRCA2-RAD51 in the DNA damage response and cancer","volume":"82","author":"Foo","year":"2022","journal-title":"Cancer Res."},{"issue":"16","key":"10.1016\/j.redox.2026.104415_bib46","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1158\/0008-5472.CAN-24-3990","article-title":"SMARCA4 loss increases RNA polymerase II pausing and elevates R-Loops to inhibit BRCA1-Mediated repair in ovarian cancer","volume":"85","author":"Zhu","year":"2025","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.redox.2026.104415_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/biom15101473","article-title":"ZC3H12A: a critical mediator of inflammation, tumor immunotherapy, and metabolic-immune crosstalk-implications for disease treatment","volume":"15","author":"Lu","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.redox.2026.104415_bib48","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.71966","article-title":"IRAK1-dependent Regnase-1-14-3-3 complex formation controls Regnase-1-mediated mRNA decay","volume":"10","author":"Akaki","year":"2021","journal-title":"eLife"},{"issue":"5","key":"10.1016\/j.redox.2026.104415_bib49","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.cell.2015.04.029","article-title":"Regnase-1 and roquin regulate a common element in inflammatory mRNAs by spatiotemporally distinct mechanisms","volume":"161","author":"Mino","year":"2015","journal-title":"Cell"},{"issue":"16","key":"10.1016\/j.redox.2026.104415_bib50","first-page":"8838","article-title":"Translation-dependent unwinding of stem-loops by UPF1 licenses Regnase-1 to degrade inflammatory mRNAs","volume":"47","author":"Mino","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.redox.2026.104415_bib51","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cell.2010.03.012","article-title":"53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks","volume":"141","author":"Bunting","year":"2010","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.redox.2026.104415_bib52","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nsmb.1831","article-title":"53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers","volume":"17","author":"Bouwman","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"1","key":"10.1016\/j.redox.2026.104415_bib53","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-026-00908-0","article-title":"Clinical application of PARP inhibitors and emerging strategies to overcome resistance: a pan-cancer perspective","volume":"14","author":"Xiang","year":"2026","journal-title":"Biomark. Res."},{"issue":"12","key":"10.1016\/j.redox.2026.104415_bib54","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41571-021-00532-x","article-title":"Understanding and overcoming resistance to PARP inhibitors in cancer therapy","volume":"18","author":"Dias","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"8007","key":"10.1016\/j.redox.2026.104415_bib55","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41586-024-07217-2","article-title":"Transcription-replication conflicts underlie sensitivity to PARP inhibitors","volume":"628","author":"Petropoulos","year":"2024","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.redox.2026.104415_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.03.056","article-title":"TBK1 and IKK\u03b5 Act redundantly to mediate STING-induced NF-\u03baB responses in myeloid cells","volume":"31","author":"Balka","year":"2020","journal-title":"Cell Rep."},{"issue":"7950","key":"10.1016\/j.redox.2026.104415_bib57","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41586-023-05704-6","article-title":"Targeting TBK1 to overcome resistance to cancer immunotherapy","volume":"615","author":"Sun","year":"2023","journal-title":"Nature"}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231726004143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231726004143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T12:15:02Z","timestamp":1792930502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231726004143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":57,"alternative-id":["S2213231726004143"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2026.104415","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The ribonuclease ZC3H12A stabilizes BRCA1 mRNA in DNA damage response","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2026.104415","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104415"}}